CDCA3在肝细胞肝癌增殖中的作用研究(5)
[12] Bi L，Zhou B，Li H，et al. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia [J]. BMC Cancer，2018，18(1)：182.
[13] Qian W，Zhang Z，Peng W，et al. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer [J]. Int J Oncol，2018，53(5)：2021-2033.
[14] Matera R，Saif MW. New therapeutic directions for advanced pancreatic cancer： cell cycle inhibitors，stromal modifiers and conjugated therapies [J]. Expert Opin Emerg Drugs，2017，22(3)：223-233.
[15] Itzel T，Scholz P，Maass T，et al. Translating bioinformatics in oncology： guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis [J]. Bioinformatics，2015，31(2)：216-224.
[16] Chen J，Zhu S，Jiang N，et al. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3 [J]. Cancer Lett，2013，330(2)：217-224.
[17] Zhang W，Lu Y，Li X，et al. CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer [J]. Biochem Biophys Res Commun.，2018，500(2)：196-203.
[18] Hu Q，Fu J，Luo B，et al. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG，CD9，CCND2 and CDCA3：a bioinformatic analysis combine with RNAi and oligonucleotide microarray [J]. Oncol Rep，2015，33(4)：1965-1975.
(收稿日期：2019-11-26 本文編辑：顾家毓), 百拇医药(刘芳 徐细明)
[13] Qian W，Zhang Z，Peng W，et al. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer [J]. Int J Oncol，2018，53(5)：2021-2033.
[14] Matera R，Saif MW. New therapeutic directions for advanced pancreatic cancer： cell cycle inhibitors，stromal modifiers and conjugated therapies [J]. Expert Opin Emerg Drugs，2017，22(3)：223-233.
[15] Itzel T，Scholz P，Maass T，et al. Translating bioinformatics in oncology： guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis [J]. Bioinformatics，2015，31(2)：216-224.
[16] Chen J，Zhu S，Jiang N，et al. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3 [J]. Cancer Lett，2013，330(2)：217-224.
[17] Zhang W，Lu Y，Li X，et al. CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer [J]. Biochem Biophys Res Commun.，2018，500(2)：196-203.
[18] Hu Q，Fu J，Luo B，et al. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG，CD9，CCND2 and CDCA3：a bioinformatic analysis combine with RNAi and oligonucleotide microarray [J]. Oncol Rep，2015，33(4)：1965-1975.
(收稿日期：2019-11-26 本文編辑：顾家毓), 百拇医药(刘芳 徐细明)